Martin Wipfli, Chairman of the Board of Directors Daniel Keist, CFO
Half Year 2021 results
1
METALL ZUG GROUP
WELCOME - REMARKS OF THE CHAIRMAN
Metall Zug took advantage of the positive economic environment in H1/2021 despite continuing challenges related to the pandemic
Wire Processing and Medical Devices recovered impressively after the slump due to the pandemic in the previous year's period
The Business Units used the additional power and competences granted by Metall Zug as well as the increased flexibility following its new strategy and the spin-off of V-ZUG
Technologycluster & Infrastructure gathers speed much earlier than expected and planned
VRmagic and Cirris, acquired in 2020, confirmed their position as small but strategically valuable companies
V-ZUGdeveloped well after the spin-off and Metall Zug's 30% stake in V-ZUG contributed with CHF 13 million to the financial result and net income
Half Year 2021 results
2
METALL ZUG GROUP
CONTENT
Group Financial Report HY 1/21
Business Units Industry
Infection Control
Medical Devices
Wire Processing
Others
Business Unit Technologycluster & Infrastructure
Sustainability @ Metall Zug
Metall Zug Group - Overview HY 1/21
Information for Investors
Half Year 2021 results
3
GROUP FINANCIAL REPORT HY 1/21
METALL ZUG GROUP
OVERVIEW HY 1/21
Significant increase of Order Entry in BUs Medical Devices, Wire Processing, Infection Control and Belimed Life Science
Group net sales of CHF 302.8 million (HY 1/20: CHF 248.2 million excluding V-ZUG), Organic sales increase of 18%
Negative FX effect of CHF 3.5 million (-1.4%). Acquisition effect of CHF 13.5 million (5.4%)
Infection Control: stable sales despite FX effect
Medical Devices and Wire Processing: strong recovery after COVID impact in 2020
Belimed Life Science with slightly lower sales due to lower level of finalized projects; Gehrig Group with lower sales due to shutdown of hotels and restaurants
Operating result (EBIT) of CHF 16.9 million (HY 1/20 CHF -14.6 million excluding V-ZUG)
Strong pickup of EBIT of BUs Medical Devices and Wire Processing due to rebound of the relevant markets
Slightly lower EBIT in Infection Control (excluding extraordinary impact in HY 1/20)
BU "Others": Belimed Life Science with further improvement of EBIT
Half Year 2021 results
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Metall Zug AG published this content on 17 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2021 13:03:11 UTC.
Metall Zug AG is a Switzerland-based holding company engaged in the industrial sector. The Company is organized, along with its subsidiaries, into four business segments: Household Appliances, Infection Control, Wire Processing and Medical Devices. The Household Appliances segment develops, produces and distributes appliances for kitchen and laundry, as well as for the hotel industry. The Infection Control segment provides equipment for medical institutions, pharmaceutical institutions and laboratories. The Wire Processing segment provides wire processing equipment. The Medical Devices segment develops, produces and distributes products and services for diagnosis and surgery. The Companyâs subsidiaries include V-ZAG AG, Gehrig Group AG, Belimed AG, Schleuniger Holding AG and Haag Streit Holding AG, among others.
METALL ZUG AG 
